Ignite Creation Date:
2024-05-06 @ 10:42 AM
Last Modification Date:
2024-10-26 @ 12:34 PM
Study NCT ID:
NCT03332927
Status:
COMPLETED
Last Update Posted:
2019-07-24
First Post:
2017-11-02
Brief Title:
Effect of Egg Consumption on Cardiometabolic Health in Prediabetic Subjects
Sponsor:
Midwest Center for Metabolic and Cardiovascular Research
Organization:
Midwest Center for Metabolic and Cardiovascular Research
Study Overview
Official Title:
A Randomized Crossover Trial to Assess the Effects of Replacing Commonly Consumed Breakfast Foods With Eggs on Insulin Sensitivity and Other Markers of Cardiometabolic Health in Men and Women at Increased Risk for Type 2 Diabetes Mellitus
Status:
COMPLETED
Status Verified Date:
2019-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The objective of this trial is to assess the effects of whole egg consumption 12 per week compared to energy-matched typical breakfast control foods on insulin sensitivity and other markers of metabolic health including fasting lipoprotein lipid levels and resting blood pressure
Detailed Description:
This is a randomized crossover study that includes two screening visits and two 4-week test periods separated by a 4-week washout Subjects will consume two eggsday 12 eggsweek consumed over 6 days per week provided as breakfast foods such as burrito-type roll-up egg sandwich and omelet or non-egg based control foods provided as breakfast foods such as English muffins bagels ready-to-eat cereal and flavored muffins The background diet will be a habitual diet The nutritional profiles of the egg and control breakfast foods will be designed such that the energy from eggs will be substituted for a mixture of carbohydrate protein and fat in the control foods
Study foods will be dispensed with instructions to consume the assigned breakfast food starting on day 1 Subjects will be instructed to consume the breakfast foods in their entirety each day for the duration of the 28 day test period and to record daily study food intake Subjects will receive diet instruction on the incorporation of food substitutions during the test period to maintain habitual energy intake Compliance will be assessed using the Daily Log intake and number of foods consumed based on returned foods
An intravenous glucose tolerance test IVGTT will be completed at baseline and the end of each treatment period for evaluation of insulin sensitivity Blood will be collected for a fasting lipid profile at all visits glucose and insulin high-sensitivity C-reactive protein hs-CRP vertical auto profile VAP for cholesterol carried by lipoprotein fractions at baseline and end of each treatment period with additional blood samples collected for storage and archived for possible future analysis of non-genetic indicators of metabolism Assessments of vital signs and body weight review of concomitant medicationsupplement use and inclusion and exclusion criteria for relevant changes and evaluation of adverse effects will be performed throughout the study
Study foods will be dispensed with instructions to consume the assigned breakfast food starting on day 1 Subjects will be instructed to consume the breakfast foods in their entirety each day for the duration of the 28 day test period and to record daily study food intake Subjects will receive diet instruction on the incorporation of food substitutions during the test period to maintain habitual energy intake Compliance will be assessed using the Daily Log intake and number of foods consumed based on returned foods
An intravenous glucose tolerance test IVGTT will be completed at baseline and the end of each treatment period for evaluation of insulin sensitivity Blood will be collected for a fasting lipid profile at all visits glucose and insulin high-sensitivity C-reactive protein hs-CRP vertical auto profile VAP for cholesterol carried by lipoprotein fractions at baseline and end of each treatment period with additional blood samples collected for storage and archived for possible future analysis of non-genetic indicators of metabolism Assessments of vital signs and body weight review of concomitant medicationsupplement use and inclusion and exclusion criteria for relevant changes and evaluation of adverse effects will be performed throughout the study
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None